Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy

Antimicrobial Clinical Trial

Official title:

Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy: a Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06455228
• Other study ID #: 2024-2233-01
• Status: Recruiting
• Phase: N/A
• Start date: March 1, 2024
• Est. completion date: July 30, 2024

Study information

• Verified date: June 2024
• Source: Sir Run Run Shaw Hospital
• Contact: Zhao Linfang
• Phone: 13588819123
• Email: 3193159[@]zju.edu.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study applies long PIVCs to patients undergoing antimicrobial therapy, and compares the effects of different placement sites, aiming to provide a reference basis for patients undergoing antimicrobial treatment to select the optimal placement site, thus reducing complications, prolonging catheter retention time, and alleviating the patient's pain.

Description:

This study investigates the use of long PIVCs in patients undergoing antimicrobial therapy, and compares the effects of different insertion sites. The aim is to provide evidence-based recommendations for the optimal placement site for long PIVCs in antimicrobial treatment, with the goals of reducing complications, prolonging catheter retention time, and alleviating patient discomfort.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 90
• Est. completion date: July 30, 2024
• Est. primary completion date: July 24, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• ? estimated time of intravenous infusion =1 week; ? age: =18 years; ? antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure < 900 mOsm/L; and ? patients were conscious and able to communicate normally; ? the catheter-to-vessel ratio is less than 45%.

Exclusion Criteria:

• ? a history of radiotherapy, thrombosis, and trauma at the catheterization site and ? plans to discharge with a catheter during the study duration.

Related Conditions & MeSH terms

• Antimicrobial

Intervention

Device:
• insert catheter
A fixed routine for pre-insertion cleaning and equipment was followed, including hand washing, placing the patient in a recumbent position, skin antisepsis, and preparation of the sterile field. Catheter insertion was performed by senior specialized nurses in the intravenous treatment room, which was a standardized setting for venipuncture.

Locations

Country	Name	City	State
China	Sir Run Run Shaw Hospital, Zhejiang University School of Medicine	Hangzhou

Sponsors (1)

Lead Sponsor	Collaborator
Sir Run Run Shaw Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of catheter-related complications	Catheter-related complications were assessed including chemical phlebitis, thrombophlebitis, catheter occlusion, bleeding, catheter-related infections, and infiltration.	After insertion of catheter
Secondary	Puncture success rate with one-attempt	The puncture success rate with one-attempt refers to the instance where the puncture needle successfully enters the target vein on the first attempt without needing to change the puncture site.	After insertion of catheter
Secondary	The procedure time	The procedure time is defined as the duration from the start of skin disinfection to the stabilization of the catheter with dressing.	After insertion of catheter.
Secondary	Indwelling catheter duration	The Indwelling catheter duration refers to the number of days between the date of catheter placement and its removal.	After insertion of catheter